Erin E. Carlson

9.9k total citations · 1 hit paper
116 papers, 4.0k citations indexed

About

Erin E. Carlson is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, Erin E. Carlson has authored 116 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 37 papers in Genetics and 19 papers in Pharmacology. Recurrent topics in Erin E. Carlson's work include Bacterial Genetics and Biotechnology (19 papers), Microbial Natural Products and Biosynthesis (15 papers) and Bacteriophages and microbial interactions (14 papers). Erin E. Carlson is often cited by papers focused on Bacterial Genetics and Biotechnology (19 papers), Microbial Natural Products and Biosynthesis (15 papers) and Bacteriophages and microbial interactions (14 papers). Erin E. Carlson collaborates with scholars based in United States, Japan and Canada. Erin E. Carlson's co-authors include Ozden Kocaoglu, Carolyn M. Slupsky, Pascal Mercier, Jack Newton, Aalim M. Weljie, Laura L. Kiessling, Darci J. Trader, Andrew R. Johnson, Benjamin F. Cravatt and Malcolm E. Winkler and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

Erin E. Carlson

113 papers receiving 3.9k citations

Hit Papers

Targeted Profiling:  Quantitative Analysis of 1H NMR Meta... 2006 2026 2012 2019 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin E. Carlson United States 36 2.2k 623 618 420 352 116 4.0k
Michaël M. Meijler Israel 35 2.7k 1.2× 699 1.1× 452 0.7× 232 0.6× 163 0.5× 99 4.2k
Jennifer L. Martin Australia 48 5.4k 2.5× 754 1.2× 816 1.3× 320 0.8× 423 1.2× 157 8.1k
Xiaodong Wang United States 34 3.2k 1.5× 643 1.0× 408 0.7× 271 0.6× 372 1.1× 131 6.1k
Hao Wang China 43 2.6k 1.2× 898 1.4× 376 0.6× 308 0.7× 281 0.8× 257 5.2k
Xi Cheng China 21 5.8k 2.7× 522 0.8× 546 0.9× 199 0.5× 271 0.8× 54 8.3k
Qiang Chen China 42 3.2k 1.5× 605 1.0× 233 0.4× 273 0.7× 409 1.2× 254 5.9k
Vidyashankara Iyer United States 10 4.4k 2.0× 480 0.8× 352 0.6× 180 0.4× 221 0.6× 12 6.3k
Wulf Blankenfeldt Germany 38 3.1k 1.4× 599 1.0× 470 0.8× 755 1.8× 249 0.7× 147 4.9k
Ignacio Fita Spain 46 3.8k 1.8× 259 0.4× 408 0.7× 278 0.7× 404 1.1× 155 6.8k
Osnat Herzberg United States 40 4.0k 1.9× 334 0.5× 674 1.1× 458 1.1× 362 1.0× 135 6.4k

Countries citing papers authored by Erin E. Carlson

Since Specialization
Citations

This map shows the geographic impact of Erin E. Carlson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin E. Carlson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin E. Carlson more than expected).

Fields of papers citing papers by Erin E. Carlson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin E. Carlson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin E. Carlson. The network helps show where Erin E. Carlson may publish in the future.

Co-authorship network of co-authors of Erin E. Carlson

This figure shows the co-authorship network connecting the top 25 collaborators of Erin E. Carlson. A scholar is included among the top collaborators of Erin E. Carlson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin E. Carlson. Erin E. Carlson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hálfdánarson, Þorvarður R., Erin E. Carlson, Kari G. Rabe, et al.. (2025). Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinoma. Endocrine Related Cancer. 32(4). 1 indexed citations
2.
Carlson, Erin E., et al.. (2023). Activity-based probes in pathogenic bacteria: Investigating drug targets and molecule specificity. Current Opinion in Chemical Biology. 76. 102359–102359. 3 indexed citations
3.
Yang, Junshu, et al.. (2023). Targeting multidrug resistant Staphylococcus infections with bacterial histidine kinase inhibitors. Chemical Science. 14(19). 5028–5037. 9 indexed citations
4.
Marshall, Andrew, et al.. (2022). Development of a single culture E. coli expression system for the enzymatic synthesis of fluorinated tyrosine and its incorporation into proteins. Journal of Fluorine Chemistry. 261-262. 110014–110014. 4 indexed citations
5.
Myasoedova, Elena, Arjun P. Athreya, Cynthia S. Crowson, et al.. (2021). Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics‐Driven Machine Learning Approach. Arthritis Care & Research. 74(6). 879–888. 33 indexed citations
6.
Perez, Amilcar J., Michael J. Boersma, Kevin E. Bruce, et al.. (2020). Organization of peptidoglycan synthesis in nodes and separate rings at different stages of cell division of Streptococcus pneumoniae. Molecular Microbiology. 115(6). 1152–1169. 24 indexed citations
7.
Carlson, Erin E., et al.. (2020). Modified nucleoside triphosphates in bacterial research for in vitro and live-cell applications. RSC Chemical Biology. 1(5). 333–351. 17 indexed citations
8.
Carlson, Erin E., et al.. (2020). 2‐Aminobenzothiazoles Inhibit Virulence Gene Expression and Block Polymyxin Resistance in Salmonella enterica. ChemBioChem. 21(24). 3500–3503. 5 indexed citations
9.
Cairns, Junmei, James N. Ingle, Tanda M. Dudenkov, et al.. (2020). Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action. JCI Insight. 5(16). 22 indexed citations
11.
Tollefson, Emily J., Gene Chong, Xi Zhang, et al.. (2019). Preferential Binding of Cytochrome c to Anionic Ligand-Coated Gold Nanoparticles: A Complementary Computational and Experimental Approach. ACS Nano. 13(6). 6856–6866. 37 indexed citations
12.
Kalari, Krishna R., Jason P. Sinnwell, Kevin J. Thompson, et al.. (2018). PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient. JCO Clinical Cancer Informatics. 2(2). 1–11. 11 indexed citations
13.
Liu, Duan, Ming‐Fen Ho, Daniel J. Schaid, et al.. (2017). Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes. npj Breast Cancer. 3(1). 30–30. 11 indexed citations
14.
Ingle, James N., Fang Xie, Matthew J. Ellis, et al.. (2016). Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy. Cancer Research. 76(23). 7012–7023. 43 indexed citations
15.
Ingle, James N., Mohan Liu, D. Lawrence Wickerham, et al.. (2013). Selective Estrogen Receptor Modulators and Pharmacogenomic Variation in ZNF423 Regulation of BRCA1 Expression: Individualized Breast Cancer Prevention. Cancer Discovery. 3(7). 812–825. 56 indexed citations
16.
Trader, Darci J. & Erin E. Carlson. (2012). Chemoselective hydroxyl group transformation: an elusive target. Molecular BioSystems. 8(10). 2484–2493. 48 indexed citations
17.
Trader, Darci J., et al.. (2011). Chemoselective enrichment for natural products discovery. Chemical Science. 2(4). 760–760. 37 indexed citations
18.
Schaid, Daniel J., Shannon K. McDonnell, Shaun M. Riska, Erin E. Carlson, & Stephen N. Thibodeau. (2009). Estimation of genotype relative risks from pedigree data by retrospective likelihoods. Genetic Epidemiology. 34(4). 287–298. 11 indexed citations
19.
Vachon, Celine M., Thomas A. Sellers, Erin E. Carlson, et al.. (2007). Strong Evidence of a Genetic Determinant for Mammographic Density, a Major Risk Factor for Breast Cancer. Cancer Research. 67(17). 8412–8418. 58 indexed citations
20.
Carlson, Erin E., et al.. (2004). A unique catalytic mechanism for UDP-galactopyranose mutase. Nature Structural & Molecular Biology. 11(6). 539–543. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026